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Abstract 
 
Introduction:  To determine whether personality traits influence self-reported functional vision in 
patients with Age-Related Macular Degeneration (AMD).   
 
Methods:  This is a prospective cross-sectional analysis of baseline data from the Low Vision 
Depression Prevention Trial.  Participants (N=182) over age 65 with bilateral AMD, visual 
acuity worse than 20/70 in the better-seeing eye, and subthreshold depression were recruited 
from the Wills Eye Hospital retina practice.   Assessments included visual acuity, contrast 
sensitivity, National Eye Institute Visual Function Questionnaire-25 plus Supplement (NEI 
VFQ) near and distance subscales, depression, and personality testing.  Structural equation 
models were used to investigate the relationship of the NEI VFQ near-activities and distance-
activities with the various demographic, clinical, and psychological predictors. 
 
Results:   In the single predictor model for near functional vision, visual acuity at logMAR ≤ 1 
(estimate  = -0.33 [95% confidence interval (CI) -0.46, -0.20]; p ≤ 0.001), neuroticism (estimate 
= - 0.05 [95% CI -0.08,-0.01]; p = 0.01), and education (estimate = -0.08 [95% CI 0.01, 0.15]; p 
= 0.03) were statistically significant predictors .  In the single predictor model for distance 
functional vision, only visual acuity at logMAR ≤ 1 (estimate = -0.49 [95% CI -0.69, -0.29]; p ≤ 
0.001) and neuroticism (estimate = - 0.09 [95% CI -0.15,0.02]; p = 0.008) were statistically 
significant predictors. 
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Discussion:  Self-reported functional vision depends on the severity of vision loss as well as the 
personality trait of neuroticism.   
 
Implications for Practitioners:  Assessment of personality traits, particularly neuroticism, may 
increase the precision of rating scales of functional vision and suggest new rehabilitative 
interventions to improve the functional vision and quality of life of patients with AMD. 
 
 
Trial Registration: clinicaltrials.gov Identifier:  NCT00572039 
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Introduction 
 
Perceived functional vision refers to the self-reported ability to perform vision-dependent 
activities and is often an outcome in epidemiological studies of vision loss and clinical trials of 
ophthalmologic and rehabilitative treatments to improve vision and everyday functioning.   
Functional vision is distinct from visual function, which more properly refers to the physiologic 
activity and function of the eyes and the visual system (Colenbrander, 2005).  In principle, 
functional vision ought to be closely tied to objective measures of visual function  but the 
correlation with visual acuity, for example, ranges from 0.5 to 0.68 (Massof, 2001; Revicki, 
2010).  This suggests that non-ophthalmologic factors may contribute to the relationship.  One of 
those factors may be the characteristic way patients perceive and report difficulty in their lives.  
Functional vision is assessed by asking patients to rate the difficulty they experience when 
performing various activities like reading newsprint or doing housework.  Their responses reflect 
their perceived difficulty, the value they place on the activity, their mood, and personality.  
Depressed mood is known to impair functional vision, perhaps through loss of interest, low self-
efficacy, and low motivation (Casten and Rovner, 2008; Horowitz, 2005; Owsley, 2004; Rovner, 
2006; Zhang, 2013).  Only a few studies have evaluated the impact of personality, which shapes 
an individual’s style of perceiving, responding to, and reporting visual difficulties (Boerner, 
2006; Rovner, 2001; Tabrett, 2012; Warrian, 2009).  In fact, personality provides a more stable 
and enduring representation of a person than depression, which tends to be transient and situation 
dependent (McCrae and Costa, 1990).   
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One facet of personality is the trait of neuroticism, which refers to the increased tendency to 
experience negative, distressing emotions (McCrae and Costa, 1990).  This trait is distributed 
normally in the population without a threshold indicative of disorder and is moderately heritable 
(Wray, 2008).  Individuals on the extreme of the distribution get upset easily by life events and 
stay upset longer than others who face similar difficulties.  They tend to be temperamental, 
anxious, and inflexible and to hold pessimistic views of themselves and their circumstances.  
Thus, given the same degree of vision loss, people high and low in neuroticism might vary 
substantially in their reporting of functional vision.  If their scores on the National Eye Institute 
Visual Function Questionnaire (NEI-VFQ) differ, we cannot assume that the person who reports 
worse functional vision (i.e., has a lower NEI VFQ score) has worse visual acuity than a person 
with a higher score (Mangione, 2001). The former person may simply have a perceptual bias that 
conveys greater distress and disability.  The extent to which this phenomenon occurs in patients 
with AMD is uncertain because no studies to our knowledge have investigated it.  If the extent is 
substantial it may confound the results of studies on vision loss and disability or on the efficacy 
of ophthalmologic and rehabilitative treatments.   In this study, we tested the hypothesis that 
personality traits would influence self-ratings of functional vision independent of objective 
measures of vision (i.e., visual acuity, contrast sensitivity) in older persons with bilateral age-
related macular degeneration (AMD).  The subjects were enrolled in the Low VIsion Depression 
Prevention TriAL (VITAL), which is a randomized controlled clinical trial that compares the 
efficacy of a combined mental health and low vision rehabilitation intervention with standard 
low vision rehabilitation to prevent depression. 
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Methods 
 
This study reports baseline data obtained before randomization into the VITAL clinical trial 
(clinicaltrials.gov:  NCT00572039).   All subjects signed an informed consent form approved by 
the Institutional Review Boards of Thomas Jefferson University and Wills Eye Hospital.  We 
recruited 182 patients with AMD from the Midatlantic Retina practice associated with the Wills 
Eye Hospital in Philadelphia, Pennsylvania between October 2009 and September 2012.  The 
inclusion criteria were:  1) age over 65 years; 2) bilateral AMD (either neovascular (i.e., “wet” 
AMD) or geographic atrophy (i.e., “dry” AMD); 3) best corrected visual acuity worse than 20/70 
in the better-seeing eye; 4) more than 5 anti-vascular endothelial growth factor (VEGF) 
injections if the better eye had “wet” AMD.  These injections (e.g., ranibizumab) reduce the 
growth of abnormal blood vessels in the macula and have greatly improved the prognosis of this 
condition (Sloan and Hanrahan, 2014).  In the present study, requiring patients with wet AMD to 
have had more than 5 anti-VEGF injections identified those whose vision was not likely to 
improve with additional anti-VEGF treatment.  This was an important consideration in this 
clinical trial of low vision rehabilitation.;  5) subthreshold depressive symptoms (defined as a 
Patient Health Questionnaire-9 score ≥ 5 or depressed mood or anhedonia several days per week; 
and 6) moderate difficulty performing a valued vision-dependent activity.  The exclusion criteria 
were: 1) on-going or anticipated anti-VEGF treatment; 2) current Diagnostic and Statistical 
Manual (DSM) IV-defined depressive disorder; 3) uncontrolled glaucoma, diabetic retinopathy, 
corneal dystrophy, or anticipated cataract surgery;  4) low vision rehabilitation within the 
previous year; and 5) cognitive impairment on an abbreviated version of the Mini-Mental Status 
Examination (MMblind) that omits vision-dependent items (Reischies, 1997).   
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Study Measures 
 
A research nurse with training in psychiatry and ophthalmology conducted in-home assessments 
to obtain demographic data and assess the following domains at baseline.   
 
Functional Vision:  The NEI VFQ-25 plus supplement was used to measure near-vision and 
distance functional vision.  The NEI VFQ is a self-rated instrument that assesses difficulty with 
daily activities, social functioning, general health, problems with vision, and quality of life 
(Mangione, 2001).  The near-vision subscale is comprised of 6 items that rate the difficulty level 
of reading newsprint; doing housework or hobbies; finding something on a crowded shelf; 
reading small print on a medication bottle or legal form; determining whether bills are accurate; 
and performing personal hygiene tasks.  The distance-vision subscale rates the difficulty of 
reading street signs or the names of stores; going down steps, stairs, or curbs in dim light or at 
night; going out to see movies or plays; recognizing people across a room; taking part in active 
sports or other outdoor activities; and seeing and enjoying programs on TV.  Subjects rated these 
items on an ordinal scale from 1 (no difficulty) to 5 (stopped doing the activity because of vision 
loss).  If subjects stopped doing an activity for non-vision reasons the item was scored as missing 
data.  Previous studies have demonstrated that these subscales are responsive to low vision 
rehabilitation and anti-VEGF treatment and can be used to estimate interval scales (Chang, 2007; 
Marella, 2010; McKean-Cowdin, 2010; Ryan, 2008; Stelmack, 2002). 
 
Vision Status:  Best-corrected vision (with current spectacles) was assessed using the 
Lighthouse Ferris-Bailey Early Treatment Diabetic Retinopathy Study chart to measure visual 
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acuity and the Pelli-Robson Contrast Sensitivity chart to measure contrast sensitivity.  Near and 
distance visual acuities were assessed at 16 inches and 5 feet (41 cm and 1.5 m), respectively, 
using back illumination.  For statistical analyses, log transformations (i.e., logMAR and log 
contrast) were used for visual acuity and contrast sensitivity, respectively.  LogMAR refers to the 
logarithm of the minimum angle of resolution, which specifies a linear scale of visual acuity, and 
recognizes that increases in letter size on visual acuity charts follow a geometric progression.  
Statistical analyses in logMAR units yield more precise comparisons. 
 
Physical Health Status:   The Chronic Disease Score (CDS) was used to assess the severity of 
comorbid medical problems.  This score is based on a weighted sum of medications taken for 
chronic diseases and is a valid predictor of health care utilization, costs, and mortality (Von 
Korff, 1992).  Higher scores indicate worse medical status.  We also used the Multilevel 
Assessment Inventory Health Conditions Check List to record the presence of acute and chronic 
medical conditions (Lawton, 1982). 
 
Depression:  The Patient Health Questionnaire-9 (PHQ-9) was used to assess depression 
(Kroenke, 2001).  This is one of the most commonly used reliable and validated depression 
assessment instruments in health care settings.  It includes the 9 criteria that define the DSM-IV 
diagnoses of depression and can be used as a continuous indicator of depression severity.  
Symptoms are scored as the frequency of occurrence over the past two weeks on an ordinal scale 
from 0 (not at all) to 3 (every day).  Scores range from 0 to 27, with higher scores indicating 
worse depression. 
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Personality:  The Revised Neuroticism, Extroversion, Openness Five Factor Inventory (NEO-
FFI) was used to assess the personality traits of neuroticism, conscientiousness, and openness to 
experience.  The NEO-FFI is a 60-item psychological personality inventory that measures these 
common personality traits (Costa and McCrae, 1992).  Higher scores signify higher standing on a 
given trait.   Extensive research substantiates the NEO’s inter-rater reliability, validity, stability 
over time, and applicability across different ages, cultures, and methods of measurement 
(McCrae, 2011). 
 
Statistical Methods   
 
Descriptive statistics for baseline demographic and clinical variables are presented as means 
(SD) for continuous data and as frequencies (percentages) for categorical data.  We used two 
separate structural equation models to investigate the relationship of the NEI VFQ near-activities 
and distance-activities subscales with the various demographic, clinical, and psychological 
predictors (Moustaki, 2003; Skrondal, 2004).  Because we expected subjects’ responses on the 
two functional vision subscales to depend on multiple variables, our models assume that each 
subject has a self-perceived ability to perform near or distance activities that is manifested by 
their responses to the 6 NEI VFQ near activity items (i.e., the composite latent variable of “near 
functional vision”), and the 6 NEI VFQ distance activities (i.e., the composite latent variable of 
“distance functional vision”), respectively.   
 
The structural equation model has two parts.  The first part reduces the 6 observed items to a 
single latent variable. The second part models the relationship between the latent variable and 
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other observed covariates through a linear regression model.  The value of the latent variable can 
be estimated for each subject based on the model parameter estimates and the subject’s observed 
NEI VFQ items and other characteristics.  While the model has two parts, the parameters of both 
parts are estimated simultaneously.   
 
The main focus of the analysis was to estimate the association between the two latent variables 
and the clinical and psychological predictors.  The latent variable is centered on zero and is 
normally distributed.  After initial fitting of the latent variable model without any explanatory 
variables, estimated latent variable scores were plotted against the clinical and psychological 
predictors to determine whether a linear relationship could be assumed.  A linear relationship 
seemed reasonable for most factors except visual acuity, which had a different relationship for 
acuities less than logMAR of 1.0 vs. those greater than 1.0.  Consequently, a piecewise 
regression model was used for visual acuity to allow for different slopes below and above 
logMAR values of 1.0.  We fit two sets of models.  The first considered the association of near or 
distance functional vision and various clinical and psychological predictors individually (single 
predictor models).  The second considered the association of near or distance functional vision 
with the predictors simultaneously (multivariable models).   The values of the latent functional 
vision variables were estimated for each subject from the multivariable models.  All structural 
equation models were fit using Mplus version 6 (Muthe’n, 2010). 
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Results 
 
The demographic, clinical, and psychological characteristics of the 182 subjects are summarized 
in Table 1.  Their mean [standard deviation (SD)] age was 84.1 (6.7) years and 129 (71%) were 
women.  The mean near visual acuity logMAR of .66 corresponds to a Snellen visual acuity of 
about 20/80.  The mean neuroticism score was 20.5 (SD 6.4).  This is nearly identical to the 
score of 20.7 (SD 7.3) that we found in an earlier study of patients with AMD and comparable to 
the average score of 19.1 (SD 7.7) in the community (Costa and McCrae, 1992; Rovner, 2001). 
The correlations of neuroticism with near visual acuity, distance visual acuity, and contrast 
sensitivity were all ≤ 0.10 and not significant.  The correlation of the NEI VFQ -25 near and 
distance subscales was 0.58; p < 0.001, indicating that these indicators of functional vision share 
some variance but assess somewhat independent domains.  
 
In the single predictor models for near functional vision, only visual acuity at logMAR ≤ 1 
(estimate  = -0.33 [95% confidence interval (CI) -0.46, -0.20]; p < 0.001), neuroticism (estimate 
= - 0.05 [95% CI -0.08,-0.01]; p = 0.01), and education (estimate = -0.08 [95% CI 0.01, 0.15]; p 
= 0.03) were statistically significant predictors .  In the single predictor model for distance 
functional vision, only visual acuity at logMAR ≤ 1 (estimate  = -0.49 [95% CI -0.69, -0.29]; p < 
0.001) and neuroticism (estimate = - 0.09 [95% CI -0.15,0.02]; p < 0.008) were statistically 
significant predictors.  These estimates represent the change in the latent functional vision 
variable associated with a 1 unit increase in the predictor (except for visual acuity where the 
change represents a 0.1 increase).  Age, sex, contrast sensitivity, Chronic Disease Score, PHQ-9 
score, conscientiousness, and openness were unrelated to the functional vision variables. 
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Table 2 shows the results of the multivariable models for near and distance functional vision 
wherein we considered the unique effect of the predictors that were significant in the single 
predictor models after controlling for the effects of the other variables.  Both models reveal that 
visual acuity at logMAR ≤ 1 and neuroticism were independently associated with difficulty with 
near and distance activities.  Age was marginally associated with near activities and significantly 
associated with distance activities.   No other variables were associated with the ability to 
perform near or distance activities after adjustment for these predictors. 
 
The Figure shows the strong correlation of both domains of functional vision with visual acuity 
at the average of all variables in the model (solid line) but also the considerable variability that 
remains. There is a noticeable flattening of the relationship of the near and distance functional 
vision with visual acuities after acuities of logMAR ≥ 1.0, which led to the introduction of the 
piecewise regression terms in the final models.  The short dash line depicts the relationship 
between visual acuity and functional vision for persons who score high in neuroticism (i.e., one 
standard deviation [6.4 points] above average).  The long dash line depicts that relationship for 
persons who score low in neuroticism (i.e., one standard deviation below average).  The 
comparison of the 2 lines indicate that at any given level of visual acuity, persons high in 
neuroticism will report worse functional vision, and persons low in neuroticism will report better 
functional vision, than the average person.  A 1 SD increase in neuroticism is associated with a 
decrease of 0.05 X 6.4 = 0.32 (or 0.25 SD) in the near functional vision latent variable.  
Similarly, for distance functional vision, a 1 SD increase in neuroticism was associated with a 
0.07 X 6.4 = 0.45 (or 0.25 SD) decrease in the latent variable.   
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Discussion 
 
Most everyday activities require a specific level of vision to complete them successfully and 
independently but whether or not someone reports difficulty when carrying them out depends on 
other factors like general health, compensatory strategies, depression, cognition, and personality 
(Clemons, 2006; Goldstein, 2012; Horowitz, 2005; Rees, 2009; Rovner, 2006; Rovner, 2011; 
Whitson, 2012).  Because personality is stable throughout the life span and shapes one’s 
characteristic responses to life circumstances, knowing if someone is disposed to optimism and 
resilience or pessimism and vulnerability is important.  It has direct relevance when functional 
vision is an outcome in a clinical trial of a new ophthalmologic treatment or rehabilitative 
approach because reporting bias may obscure treatment effects.   In fact, accounting for reporting 
bias is relevant to treatment responses in any disease in which the relationships between the 
disease, disease perception, symptom reporting, and illness behavior are complex.  In clinical 
practice, clinicians intuitively incorporate a patient’s personality, or reporting style, into their 
formulation of the patient’s disease severity and disability but in research, where a surveyor 
lacks informed knowledge of the person and the disease, discerning this relationship is more 
difficult.  The result is that bias is introduced systematically to the extent that persons high in 
neuroticism, who report more somatic complaints and disability, are represented in population or 
clinic-based samples (Costa and McCrae, 1985; Lockenhoff, 2008). 
 
We found, as expected, that visual acuity was strongly correlated with both near and distance 
functional vision.  The personality trait of neuroticism was also associated with both domains of 
functional vision.  Studying  a sample of adults with mixed visual impairment (the majority of 
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whom had macular disease), Tabrett and Latham (2012) found that lower levels of neuroticism 
were significantly associated with better adjustment to vision loss independent of severity of 
vision loss, vision-related activity loss, and duration of vision loss.  Interestingly,  Warrian et al 
(2008), however, found no significant correlations between neuroticism and near or distance 
functional vision in patients with glaucoma, perhaps because glaucoma and AMD cause different 
types of vision loss (i.e., peripheral versus central loss, respectively).  
 
In terms of other variables we examined, we found that contrast sensitivity added no additional 
explanatory value after controlling for visual acuity.  Depression was also not related to 
functional vision, likely because variability in depressive symptoms was limited, as we enrolled 
patients with a narrow, low range of depressive symptoms (i.e., patients with severe depression 
or no depression were excluded).  Aside from the weak correlations with older age, no other 
demographic, medical, or personality characteristics were related to functional vision after 
controlling for visual acuity and neuroticism.  Other studies have reached similar conclusions.  
Russo et al (1997) demonstrated in a primary care population that neuroticism explained 
significant variance in disability independent of demographics, medical comorbidity, and 
depression.  Costa and McCrae (1987) found that neuroticism was related to increased somatic 
complaints but not objective signs of disease in persons with coronary artery disease.  
 
Although our results are consistent with these studies, they must be viewed in light of this 
study’s limitations.  The subjects were drawn from specialty eye clinics, had specific vision and 
other clinical characteristics, and had enrolled in a clinical trial to prevent depression.  These 
unique factors limit generalizability. The study also lacked measures of retinal pathology, other 
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measures of vision (e.g., visual fields), and performance-based tests that might better 
characterize the direct effects of AMD on functional vision. The strengths of the study include 
the large sample size, systematic ascertainment and assessment of patients whose visual, 
psychological, medical, and functional characteristics were evaluated using instruments of 
known reliability and validity, and the use of structural equations to estimate an interval scale of 
functional vision.   
 
The present data suggest that the personality trait of neuroticism is related to self-reported 
functional vision, and that this trait may affect the results of vision research studies and the care 
of patients.  For researchers who use the NEI VFQ in clinical trials, measuring neuroticism may 
reduce the confounding effect of reporting bias on self-rated outcomes and identify subgroups of 
patients for whom an intervention is more or less effective.  For this reason, researchers may 
want to consider administering the 12–item Neuroticism subscale of the NEO-FFI (which takes 
only about 5 minutes to administer) to control for this factor.  For low vision rehabilitative and 
other clinical practitioners, encountering patients whose functional vision is worse than expected, 
given the objective measures of vision (e.g., visual acuity), should prompt consideration of 
nonophthalmologic factors in the genesis of the patient’s difficulty.  Although we recognize that 
vision loss is distressing to almost everyone, most individuals adapt relatively quickly, 
compensate for impairments, and establish a new equilibrium.   Persons who are high in 
neuroticism, however, adapt less well and experience persistent distress and disability.  
Rehabilitation specialists working with such patients might first recognize and accept, rather than 
minimize or be repelled by the latters’ disproportionate emotionalism and cognitive distortions 
(e.g. “I’ll never get better”), and reassure them that as they do more in rehabilitation their sense 
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of self-efficacy and functional abilities will improve (Alma, 2013).    Besides requiring more 
time and sensitivity, neuroticism translates to higher healthcare costs.  The economic costs of 
neuroticism exceed those of common mental and physical disorders, ranging from low per capita 
costs for persons at the lowest level of neuroticism (< $3,000) to very high costs among those at 
the highest level (>$22, 000) (Cuijpers, 2010).  These higher costs are often driven by 
exaggerated negative health perceptions and resulting excess medical service use but might be 
mitigated with appropriate recognition and treatment.  
 
As the population ages and the prevalence of disabling chronic diseases increases, understanding 
the role of person-level factors, often ones that fall outside the traditional medical model, will 
become increasingly important.  This is especially true as Accountable Care Organizations begin 
to provide comprehensive care to populations of people, whose perceptions of health and 
disability depend as much at times on personality as on clinical factors (Lockenhoff, 2008).  This 
fact recommends the use of brief, validated personality screening tests to identify persons with 
high levels of neuroticism.  Once identified, referral to mental health treatment may be helpful.  
The selective serotonin uptake inhibitor, paroxetine, appears to have a specific pharmacological 
effect on neuroticism when used to treat depression, and cognitive and behavior activation 
therapies may also have beneficial effects (Andrews, 1996; Tang, 2009).  These promising 
treatments may mitigate the negative impact of this vulnerability factor (e.g., reduce the effect of 
distress on healthcare use) and may improve the functional vision of older persons with AMD.  
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Figure caption 
 
Figure 1.  Scatterplot of Near and Distance Functional Vision versus Visual Acuity 
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